脑肿瘤患者颅脑手术后手术部位感染的发生率与危险因素:系统综述与Meta分析
该系统综述与Meta分析纳入37项研究、91,907例接受颅脑手术的脑肿瘤患者,汇总30天和90天手术部位感染(SSI-CRAN)发生率分别为4.03%和6.17%,后颅窝肿瘤术后最高为9.67%。危险因素包括再次干预、既往放疗、手术时间较长和脑脊液漏。
要点
- 30天SSI-CRAN汇总发生率为4.03%(95%CI 2.94%-5.28%),90天为6.17%(95%CI 3.16%-10.07%)。
- 后颅窝肿瘤术后SSI-CRAN发生率最高,为9.67%(95%CI 5.98%-14.09%)。
- 危险因素包括再次干预、既往放疗、手术时间较长和脑脊液漏。
核心结论
- SSI-CRAN影响最多每14例脑肿瘤患者中的1例,高危组包括再次干预、既往放疗、手术时间较长和脑脊液漏者。
- 作者认为进一步的前瞻性研究应关注降低SSI-CRAN的集束化护理措施。
研究设计与样本
- 系统检索Medline、Embase和Cochrane Central数据库的系统综述与Meta分析。
- 纳入37项研究,共91,907例接受颅脑手术的脑肿瘤患者。
- 主要结局为30天和90天SSI-CRAN发生率,次要结局为SSI-CRAN危险因素。
主要发现
- 30天SSI-CRAN汇总发生率为4.03%(95%CI 2.94%-5.28%,I²=97.3)。
- 90天SSI-CRAN汇总发生率为6.17%(95%CI 3.16%-10.07%,I²=97.3)。
- 后颅窝肿瘤术后SSI-CRAN发生率最高,为9.67%(95%CI 5.98%-14.09%,I²=75.5)。
- 30天内再入院总体汇总发生率为13.9%(95%CI 12.5%-15.5%,I²=0.0),因SSI-CRAN再手术总体汇总发生率为16.3%(95%CI 5.4%-31.3%,I²=72.9)。
关键数值与推荐
- 再次干预者SSI-CRAN风险比RR 1.58(95%CI 1.22-2.04,I²=0.0)。
- 既往放疗者RR 1.69(95%CI 1.20-2.38,I²=0.0)。
- 手术时间较长者均数差64.18分钟(95%CI 3.96-124.40分钟,I²=90.3)。
- 脑脊液漏者RR 14.26(95%CI 2.14-94.90,I²=73.2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 30天SSI-CRAN汇总发生率的异质性I²=97.3。
- 90天SSI-CRAN汇总发生率的异质性I²=97.3。
- 后颅窝肿瘤术后SSI-CRAN发生率的异质性I²=75.5。
- 因SSI-CRAN再手术汇总发生率的异质性I²=72.9。
- 手术时间较长均数差的异质性I²=90.3,脑脊液漏RR的异质性I²=73.2。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical site infections after craniotomy (SSI-CRANs) are a serious adverse event given the proximity of the wound to the central nervous system. SSI-CRANs are associated with substantial patient morbidity and mortality. Despite the importance and recognition of this event in other surgical fields, there is a paucity of evidence in the neurosurgical literature devoted to SSI-CRAN specifically in patients after brain tumor surgery. METHODS: Systematic searches of Medline, Embase, and Cochrane Central were undertaken. The primary outcome was the incidence of SSI-CRAN at 30 and 90 days. Secondary outcomes were risk factors for SSI-CRAN. RESULTS: Thirty-seven studies reporting 91,907 patients with brain tumors who underwent cranial surgery were included in the meta-analysis. Pooled incidence of SSI-CRAN at 30 and 90 days was 4.03% (95% CI: 2.94%-5.28%, I2 = 97.3) and 6.17% (95% CI: 3.16%-10.07%, I2 = 97.3), respectively. Specifically, incidence of SSI-CRAN following surgery for posterior fossa tumors was the highest at 9.67% (95% CI: 5.98%-14.09%, I2 = 75.5). Overall pooled incidence of readmission within 30 days and reoperation due to SSI-CRAN were 13.9% (95% CI: 12.5%-15.5%, I2 = 0.0) and 16.3% (95% CI: 5.4%-31.3%, I2 = 72.9), respectively. Risk factors for SSI-CRAN included reintervention (risk ratio [RR] 1.58, 95% CI: 1.22-2.04, I2 = 0.0), previous radiotherapy (RR 1.69, 95% CI: 1.20-2.38, I2 = 0.0), longer duration of operation (mean difference 64.18, 95% CI: 3.96-124.40 minutes, I2 = 90.3) and cerebrospinal fluid (CSF) leaks (RR 14.26, 95% CI: 2.14-94.90, I2 = 73.2). CONCLUSIONS: SSI-CRAN affects up to 1 in 14 patients with brain tumors. High-risk groups include those with reintervention, previous radiotherapy, longer duration of operation, and CSF leaks. Further prospective studies should focus on bundles of care that will reduce SSI-CRAN.
引用
- Lee KS, Borbas B, Plaha P, et al. Incidence and Risk Factors of Surgical Site Infection After Cranial Surgery for Patients with Brain Tumors: A Systematic Review and Meta-analysis. World Neurosurg. 2024. PMID: 38432506. doi:10.1016/j.wneu.2024.02.133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。